Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Radnet ( (RDNT) ) has shared an update.
On July 17, 2025, RadNet, Inc. announced the completion of its acquisition of iCAD, Inc., a leader in AI-powered breast health solutions. This acquisition, through RadNet’s subsidiary DeepHealth, integrates iCAD’s technology and capabilities, enhancing DeepHealth’s suite of AI-powered breast cancer image interpretation and workflow solutions. The merger is expected to accelerate AI adoption and expand access to advanced breast cancer screening technologies globally, impacting over 10 million mammograms annually and improving cancer detection rates and workflow efficiency.
The most recent analyst rating on (RDNT) stock is a Buy with a $94.00 price target. To see the full list of analyst forecasts on Radnet stock, see the RDNT Stock Forecast page.
Spark’s Take on RDNT Stock
According to Spark, TipRanks’ AI Analyst, RDNT is a Outperform.
Radnet’s strong revenue growth and strategic investments in advanced imaging and digital health are significant positives. However, profitability challenges, high leverage, and valuation concerns weigh on the overall score. The recent corporate financing move supports future growth, enhancing the company’s strategic outlook.
To see Spark’s full report on RDNT stock, click here.
More about Radnet
RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States, with a network of 401 outpatient imaging centers across several states. The company offers radiology information technology and artificial intelligence solutions under the DeepHealth brand, alongside teleradiology services and other related products. RadNet employs over 11,000 individuals, including contracted radiologists, and focuses on delivering high-quality, cost-effective diagnostic imaging services.
Average Trading Volume: 658,828
Technical Sentiment Signal: Buy
Current Market Cap: $4.16B
Find detailed analytics on RDNT stock on TipRanks’ Stock Analysis page.